Leucine is a major regulator of muscle protein synthesis in neonates

Area of Science:

• Neonatal nutrition
• Pediatric growth and development
• Biochemistry of muscle growth

Background:

• Low birth weight (LBW) affects approximately 10% of US infants, often leading to neonatal growth failure.
• LBW infants face challenges with feeding tolerance, protein intake, and high nutrient demands for growth.
• Understanding nutritional regulation of growth is crucial for developing strategies to improve lean gain in LBW infants.

Purpose of the Study:

• To investigate the role of specific nutrients, particularly leucine, in stimulating muscle protein synthesis.
• To evaluate the potential of leucine supplementation for improving growth in low birth weight infants.
• To understand the mechanisms by which amino acids and insulin regulate protein synthesis.

Main Methods:

• Review of existing animal model studies on postprandial muscle protein synthesis.
• Analysis of the anabolic properties of leucine and its metabolites (α-ketoisocaproic acid, β-hydroxy-β-methylbutyrate).
• Examination of studies involving parenteral and enteral leucine supplementation in neonatal pigs.

Main Results:

• Muscle protein synthesis significantly increases postprandially due to rises in amino acids and insulin.
• Both amino acids and insulin independently stimulate protein synthesis via a mammalian target of rapamycin (mTOR)-dependent pathway.
• Leucine and its metabolites possess unique anabolic properties demonstrated in animal models.

Conclusions:

• Leucine supplementation, administered parenterally or enterally, enhances muscle protein synthesis.
• Leucine is a promising candidate for therapeutic strategies aimed at promoting growth in low birth weight infants.
• Further research into leucine's role can optimize nutritional support for neonatal growth.